All Articles

Browse the full archive, newest first.

Exploring a Promising Healthcare Stock for Long-Term Wealth Potential

An examination of a healthcare stock that may offer significant wealth-building opportunities over the next decade.

X-ray Data from Perseus Cluster Forces Reevaluation of Supernova Chemistry Models

Recent X-ray observations from the Perseus Cluster have uncovered significant discrepancies in existing supernova chemical models, prompting a critical reassessment of astrophysical theories.

Editorial Staff Apr 19

Life

The Browning of Local Waterways: Impacts on Fish Populations

Local lakes, streams, and ponds are increasingly brown, which is influencing the types of fish that thrive or struggle in these environments.

Editorial Staff Apr 19

Money

The Future of Mining: Considerations for Our Children

As mining continues to evolve, it is crucial to examine its long-term effects on future generations. This editorial reflects on the implications of mining practices.

Editorial Staff Apr 19

Money

Escalating Tensions: Trump's Threats Against Iran and Their Impact on Nuclear Talks

As tensions rise between the US and Iran, Trump's recent threats of destruction complicate ongoing uranium enrichment negotiations, with potential ramifications for international agreements.

Editorial Staff Apr 19

Money

Telix Pharmaceuticals Initiates Phase 3 Trial for Brain Cancer Treatment

Telix Pharmaceuticals has commenced a significant Phase 3 trial aimed at evaluating a new therapy for brain cancer, marking a crucial step in their research efforts.

Editorial Staff Apr 19

Money

Zai Lab and Amgen Collaborate on Lung Cancer Therapy Evaluation

Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.

Editorial Staff Apr 19

Money

Calumet Completes $150 Million Senior Notes Private Placement

Calumet (CLMT) has finalized a private placement of senior notes, raising $150 million to support its financial strategy.

Editorial Staff Apr 19

Money

Ultragenyx's Gene Therapy for Sanfilippo Syndrome Receives FDA Acceptance

The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.

Editorial Staff Apr 19

Money

Evaluating Sigma Lithium's Valuation Amid New Financing and Production Projections

An overview of Sigma Lithium's recent financing achievements and production forecasts, highlighting its growth potential.

Editorial Staff Apr 19